Assignee
AVENTIS PHARMA INC
US·189 granted patents·73 pending applications·3,043 citations·filing 1993–2013
Top patents by PatentIndex Score
262 records- 0199US6528526B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Mar 4, 2003·305 cites·37 claims
- 0299US6524347B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Feb 25, 2003·307 cites·11 claims
- 0398US6482834B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2001·Granted Nov 19, 2002·254 cites·50 claims
- 0496US6897208B2BenzimidazolesAVENTIS PHARMA INC·Filed 2002·Granted May 24, 2005·168 cites·38 claims
- 0595US6897207B2AzaindolesAVENTIS PHARMA INC·Filed 2002·Granted May 24, 2005·120 cites·50 claims
- 0693US6645969B1Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseAVENTIS PHARMA INC·Filed 1995·Granted Nov 11, 2003·74 cites·12 claims
- 0792US7943616B2Azaindoles for inhibiting aurora2 and other kinasesAVENTIS PHARMA INC·Filed 2004·Granted May 17, 2011·61 cites·1 claims
- 0892US7772252B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 0991US7977310B2Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetesAVENTIS PHARMA INC·Filed 2008·Granted Jul 12, 2011·19 cites·10 claims
- 1091US7405196B2Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetesAVENTIS PHARMA INC·Filed 2004·Granted Jul 29, 2008·43 cites·48 claims
- 1191USRE39198EHeteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesicsAVENTIS PHARMA INC·Filed 2000·Granted Jul 18, 2006·19 cites·147 claims
- 1291US6846815B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2003·Granted Jan 25, 2005·28 cites·18 claims
- 1390US6140345A1-(aryloxyalkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesicsAVENTIS PHARMA INC·Filed 1995·Granted Oct 31, 2000·32 cites·67 claims
- 1489US6413974B16,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purinesAVENTIS PHARMA INC·Filed 1999·Granted Jul 2, 2002·94 cites·27 claims
- 1588US7253165B2Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonistsAVENTIS PHARMA INC·Filed 2004·Granted Aug 7, 2007·24 cites·211 claims
- 1687US7517889B22,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonistsAVENTIS PHARMA INC·Filed 2007·Granted Apr 14, 2009·11 cites·13 claims
- 1787US7326792B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2004·Granted Feb 5, 2008·29 cites·26 claims
- 1887US7179821B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted Feb 20, 2007·7 cites·2 claims
- 1987US6881555B2AKT nucleic acids, polypeptides, and uses thereofAVENTIS PHARMA INC·Filed 2000·Granted Apr 19, 2005·15 cites·50 claims
- 2087US6693072B2Elastase inhibitorsAVENTIS PHARMA INC·Filed 2000·Granted Feb 17, 2004·21 cites·11 claims
- 2186US8008491B2Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)AVENTIS PHARMA INC·Filed 2008·Granted Aug 30, 2011·15 cites·2 claims
- 2286US7138524B2Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereofAVENTIS PHARMA INC·Filed 2002·Granted Nov 21, 2006·16 cites·1 claims
- 2386US7109161B1Preserved pharmaceutical formulationsAVENTIS PHARMA INC·Filed 2000·Granted Sep 19, 2006·36 cites·45 claims
- 2486US6479487B16, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purinesAVENTIS PHARMA INC·Filed 1999·Granted Nov 12, 2002·78 cites·193 claims
- 2585US7741493B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2007·Granted Jun 22, 2010·8 cites·10 claims
- 2685US7230015B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted Jun 12, 2007·5 cites·2 claims
- 2784US7259154B2PyrrolopyrimidinesAVENTIS PHARMA INC·Filed 2003·Granted Aug 21, 2007·26 cites·16 claims
- 2884US6977263B2Chemical compoundsAVENTIS PHARMA INC·Filed 2001·Granted Dec 20, 2005·27 cites·59 claims
- 2984US6967210B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2002·Granted Nov 22, 2005·14 cites·24 claims
- 3084US6696434B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2002·Granted Feb 24, 2004·14 cites·62 claims
- 3184US6512161B1Transgenic rabbit that expresses a functional human lipoprotein (a)AVENTIS PHARMA INC·Filed 1999·Granted Jan 28, 2003·76 cites·22 claims
- 3284US6113942APharmaceutical composition for piperidinoalkanol compoundsAVENTIS PHARMA INC·Filed 1998·Granted Sep 5, 2000·36 cites·5 claims
- 3383US7754678B2Membrane penetrating peptides and uses thereofAVENTIS PHARMA INC·Filed 2005·Granted Jul 13, 2010·8 cites·12 claims
- 3483US7534803B2Method of treating demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted May 19, 2009·4 cites·2 claims
- 3583US6613779B2Use of R(+) -α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disordersAVENTIS PHARMA INC·Filed 2001·Granted Sep 2, 2003·18 cites·25 claims
- 3682US6576647B2Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-oneAVENTIS PHARMA INC·Filed 2001·Granted Jun 10, 2003·25 cites·22 claims
- 3782US6472505B1Peptide parathyroid hormone analogsAVENTIS PHARMA INC·Filed 1999·Granted Oct 29, 2002·67 cites·8 claims
- 3882US6376472B1Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesAVENTIS PHARMA INC·Filed 1998·Granted Apr 23, 2002·24 cites·15 claims
- 3982US6194406B1Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseaseAVENTIS PHARMA INC·Filed 1997·Granted Feb 27, 2001·33 cites·161 claims
- 4081US7625889B2Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonistsAVENTIS PHARMA INC·Filed 2007·Granted Dec 1, 2009·7 cites·12 claims
- 4181US6399633B1Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferationAVENTIS PHARMA INC·Filed 1999·Granted Jun 4, 2002·61 cites·15 claims
- 4280US7169925B2Indole derivatives as interleukin-4 gene expression inhibitorsAVENTIS PHARMA INC·Filed 2003·Granted Jan 30, 2007·14 cites·11 claims
- 4380US6794410B2Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosisAVENTIS PHARMA INC·Filed 2002·Granted Sep 21, 2004·21 cites·1 claims
- 4480US6555328B1Screening methods for altering circadian rhythms and for human casein kinase I δ and/or ε phosphorylation of human clock proteins, period 1, -2 and -3AVENTIS PHARMA INC·Filed 2000·Granted Apr 29, 2003·24 cites·57 claims
- 4580US6211199B1Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseasesAVENTIS PHARMA INC·Filed 1997·Granted Apr 3, 2001·29 cites·119 claims
- 4679US7056720B2LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapiesAVENTIS PHARMA INC·Filed 2002·Granted Jun 6, 2006·8 cites·9 claims
- 4778US7135571B2Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereofAVENTIS PHARMA INC·Filed 2002·Granted Nov 14, 2006·9 cites·1 claims
- 4878US6638717B2Microarray-based subtractive hybridzationAVENTIS PHARMA INC·Filed 1999·Granted Oct 28, 2003·82 cites·5 claims
- 4978US6451815B1Method of enhancing bioavailability of fexofenadine and its derivativesAVENTIS PHARMA INC·Filed 1999·Granted Sep 17, 2002·68 cites·30 claims
- 5077US7642249B2Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonistAVENTIS PHARMA INC·Filed 2008·Granted Jan 5, 2010·6 cites·3 claims
Showing the top 50 of 262 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AVENTIS PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →